Drugs Made In America Acquisiti
DMAAR
Last
$0.13
Day
+15.9%
1y
-30.6%
5y
-17.2%
52w
-48.6%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.13
EMA 50
0.13
EMA 200
0.13
20d high
-3.8%
5y high
-48.6%
5y range
42th
Positions held
Your positionsDMAAR isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-5
Hold
avoid
Signal
Sell
Target
$0.16
Stop
$0.10
Stop distance
21.6%
Target vs last
+25.5%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -0.42 | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | -17.9% | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | 0.02 | Free cash flow | — | Analyst recommendation | none | Mean target | — |
| 52w high | $0.13 | 52w low | $0.13 |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsDMAAR · daily+10.6% over 13 sessions
Close EMA21 EMA50 EMA200